Viridian Therapeutics, Inc. (VRDN)
14.95
-0.43
(-2.80%)
USD |
NASDAQ |
Apr 10, 16:00
14.66
-0.29
(-1.94%)
After-Hours: 20:00
Viridian Therapeutics Market Cap : 1.528B for April 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 29.18M |
| Amgen, Inc. | 189.22B |
| Boston Scientific Corp. | 91.69B |
| Plus Therapeutics, Inc. | 32.94M |
| Nutriband, Inc. | 47.41M |
Market Cap Related Metrics
| PS Ratio | 17.89 |
| PEG Ratio | -4.633 |
| Price to Book Value | 2.589 |
| Price | 14.95 |
| Earnings Yield | -25.46% |
| PEGY Ratio | -4.633 |